These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 33183767)

  • 1. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
    Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
    Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligoclonal selection of nanobodies targeting vascular endothelial growth factor.
    Ahadi M; Ghasemian H; Behdani M; Kazemi-Lomedasht F
    J Immunotoxicol; 2019 Dec; 16(1):34-42. PubMed ID: 30409071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody.
    Kazemi-Lomedasht F; Behdani M; Bagheri KP; Habibi-Anbouhi M; Abolhassani M; Arezumand R; Shahbazzadeh D; Mirzahoseini H
    Mol Immunol; 2015 May; 65(1):58-67. PubMed ID: 25645505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library.
    Yan J; Wang P; Zhu M; Li G; Romão E; Xiong S; Wan Y
    J Nanobiotechnology; 2015 May; 13():33. PubMed ID: 25944262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of camel nanobodies specific for superfolder GFP fusion proteins.
    Twair A; Al-Okla S; Zarkawi M; Abbady AQ
    Mol Biol Rep; 2014 Oct; 41(10):6887-98. PubMed ID: 25085037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
    Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Inhibition of Pathologic Angiogenesis using Combination Therapy of Anti-Epcam and Anti-VEGFR2 Nanobodies.
    Karami E; Azizi P; Behdani M; Kazemi-Lomedasht F
    Curr Pharm Des; 2023; 29(13):1059-1066. PubMed ID: 37078346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies.
    Dhaouadi S; Ben Abderrazek R; Loustau T; Abou-Faycal C; Ksouri A; Erne W; Murdamoothoo D; Mörgelin M; Kungl A; Jung A; Ledrappier S; Benlasfar Z; Bichet S; Chiquet-Ehrismann R; Hendaoui I; Orend G; Bouhaouala-Zahar B
    Front Immunol; 2021; 12():635166. PubMed ID: 33790905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
    Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
    Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and characterization of specific nanobody against neuropilin-1 for inhibition of angiogenesis.
    Naderi S; Roshan R; Ghaderi H; Behdani M; Mahmoudi S; Habibi-Anbouhi M; Shokrgozar MA; Kazemi-Lomedasht F
    Mol Immunol; 2020 Dec; 128():56-63. PubMed ID: 33070092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
    Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
    Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
    Xia X; M M; Zhai T; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of a human nanobody against VEGFR-2.
    Ma L; Gu K; Zhang CH; Chen XT; Jiang Y; Melcher K; Zhang J; Wang M; Xu HE
    Acta Pharmacol Sin; 2016 Jun; 37(6):857-64. PubMed ID: 27108602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application.
    Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X
    Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of nanobodies against rhGH expressed as sfGFP fusion protein.
    Abbady AQ; Al-Shemali R; Mir Assaad J; Murad H
    Gen Comp Endocrinol; 2014 Aug; 204():33-42. PubMed ID: 24859761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Recombinant Monospecific Anti-PLGF Bivalent Nanobody and Evaluation of it in Angiogenesis Modulation.
    Nikooharf A; Arezumand R; Mansouri K; Khoshi AH; Namdar Ahmadabad H
    Mol Biotechnol; 2020 Dec; 62(11-12):580-588. PubMed ID: 32975735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction.
    Huet HA; Growney JD; Johnson JA; Li J; Bilic S; Ostrom L; Zafari M; Kowal C; Yang G; Royo A; Jensen M; Dombrecht B; Meerschaert KR; Kolkman JA; Cromie KD; Mosher R; Gao H; Schuller A; Isaacs R; Sellers WR; Ettenberg SA
    MAbs; 2014; 6(6):1560-70. PubMed ID: 25484045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Immunotoxin Targeting Epithelial Cell Adhesion Molecule Using Single Domain Antibody Fused to Diphtheria Toxin.
    Roshan R; Naderi S; Behdani M; Ahangari Cohan R; Kazemi-Lomedasht F
    Mol Biotechnol; 2023 Apr; 65(4):637-644. PubMed ID: 36129635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.
    Shoae-Hassani A; Mortazavi-Tabatabaei SA; Sharif S; Madadi S; Rezaei-Khaligh H; Verdi J
    Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):75-83. PubMed ID: 23224340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.